NPCE icon

Neuropace

48 hedge funds and large institutions have $103M invested in Neuropace in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

5% less capital invested

Capital invested by funds: $109M → $103M (-$5.97M)

6% less funds holding

Funds holding: 5148 (-3)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1 +$3.35M
2 +$820K
3 +$376K
4
BlackRock
BlackRock
New York
+$236K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$192K

Top Sellers

1 -$1.68M
2 -$440K
3 -$291K
4
Two Sigma Investments
Two Sigma Investments
New York
-$250K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$246K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23.7M
2
$17.4M
3
$17M
4
$8.71M
5
$6.94M
6
$5.16M
7
$4.91M
8
$4.24M
9
$3.35M
10
$2.87M
11
$2.21M
12
$1.74M
13
$1.11M
14
$1.08M
15
$606K
16
$255K
17
$231K
18
$169K
19
$156K
20
$144K
21
$128K
22
$125K
23
$115K
24
$99.8K
25
$93.1K